✨ Your Portfolio is fetched and updated from zerodha.
Large
Market Cap
₹99,798 Cr.
P/E
21.83

Key Ratios

Market cap
Market cap
99,798 Cr
PE
PE
21.83
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
18.89
ROCE (%)
ROCE (%)
24.94
Div Yield (%)
Div Yield (%)
0.62
Sales
Sales
23,607 Cr
OPM (%)
OPM (%)
29.48 %
Debt to Equity
Debt to Equity
-
About
Zydus Lifesciences is in the Miscellaneous sector with a M.cap of 99798.00 Cr and a PE… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Zydus Lifesciences Ltd. Business

Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an integrated pharmaceutical company based in India. They cover the entire value chain from research to distribution, specializing in API and human formulations.

Zydus Lifesciences major competitors are Mankind Pharma, Dr. Reddy's Lab, Lupin, Torrent Pharma, Cipla, Abbott India, Alkem Laboratories.
Market Cap of Zydus Lifesciences is ₹99,683 Crs.
While the median market cap of its peers are ₹1,03,972 Crs.

Zydus Lifesciences seems to be less financially stable compared to its competitors.
Altman Z score of Zydus Lifesciences is 7.91 and is ranked 5 out of its 8 competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material